DENVER, July 25, 2011 /PRNewswire/ -- FusionPharm, Inc.
(PINKSHEETS: FSPM), is proud to announce the addition of
Shane Bohlender as CFO. Mr.
Bohlender, a seasoned CPA with 18 years of experience, worked for
Deloitte in San Francisco and
New York, PWC in London, headed the finance department of a
subsidiary of France Telecom, and recently graduated from
Thunderbird's esteemed Executive MBA program.
"As the company moves towards achieving a fully reporting status
by years end I will provide clear reporting of the company's
financial position and its future potential and will help Mr.
Dittman realize that potential. I see a great future for
FusionPharm and immediate value in its services to this new and
growing industry. We have the right people in the right place at
the right time, and are positioned to become the top nationwide
service provider.
ABOUT FUSIONPHARM, INC.
FusionPharm, Inc. (www.fusionpharminc.com) provides a focused
variety of support products and ancillary services primarily to the
medical cannabis industry. More specifically, FusionPharm provides
specialty equipment, financing, consulting and other
industry-specific services to Medical Cannabis Centers, Infused
Product Manufacturers and cultivation professionals primarily in
the State of Colorado.
The Company is NOT engaged in growing, harvesting,
cultivation, possession or distribution of marijuana.
NOTES ABOUT FORWARD-LOOKING STATEMENTS :
Except for any historical information contained herein, the
matters discussed in this press release contain forward-looking
statements that involve risks and uncertainties, including those
described in the Company's Securities and Exchange Commission
reports and filings. Certain statements contained in this release
that are not historical facts constitute forward-looking
statements, within the meaning of the Private Securities Litigation
Reform Act of 1995, and are intended to be covered by the safe
harbors created by that Act. Reliance should not be placed on
forward-looking statements because they involve unknown risks,
uncertainties and other factors, which may cause actual results,
performance or achievements to differ materially from those
expressed or implied. Forward-looking statements may be identified
by words such as estimates, anticipates, projects, plans, expects,
intends, believes, should and similar expressions and by the
context in which they are used. Such statements are based upon
current expectations of the Company and speak only as of the date
made. The Company undertakes no obligation to update any
forward-looking statements to reflect events or circumstances after
the date on which they are made.
SOURCE FusionPharm, Inc.